Home/Filings/4/0001181431-11-049124
4//SEC Filing

Ruegsegger Frederick J 4

Accession 0001181431-11-049124

CIK 0001178711other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 6:38 PM ET

Size

4.9 KB

Accession

0001181431-11-049124

Insider Transaction Report

Form 4
Period: 2011-09-13
Transactions
  • Purchase

    Common Stock

    2011-09-13$2.86/sh+15,000$42,93315,000 total
Footnotes (1)
  • [F1]The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $2.83 to $2.89 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1
  • filerCIK 0001428158

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:38 PM ET
Size
4.9 KB